A community approach to mortality prediction in sepsis via gene expression analysis

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Sweeney, Timothy E ^a,w   Perumal, Thanneer M ^b   Henao, Ricardo ^c,d   Nichols, Marshall ^c   Howrylak, Judith A ^e   Choi, Augustine M ^f   Bermejo Martin, Jesús F ^g   Almansa, Raquel ^g   Tamayo, Eduardo ^g   Davenport, Emma E ^h,i,j   Burnham, Katie L ^k   Hinds, Charles J ^l   Knight, Julian C ^k   Woods, Christopher W ^c,m   Kingsmore, Stephen F ⁿ   Ginsburg, Geoffrey S ^c   Wong, Hector R ^o,p   Parnell, Grant P ^q   Tang, Benjamin ^q,r,s,t   Moldawer, Lyle L ^u   Moore, Frederick E ^u   Omberg, Larsson ^b   Khatri, Purvesh ^a   Tsalik, Ephraim L ^c,m   Mangravite, Lara M ^b   Langley, Raymond J ^v   more..

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAGE BIONETWORKS   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Duke University   (United States)

^e PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^f WEILL CORNELL MEDICAL CENTER   (United States)

^g HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ LABORATORY FOR MOLECULAR MEDICINE   (United States)

^j BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^m DURHAM VA HEALTH CARE SYSTEM   (United States)

ⁿ RADY CHILDREN S INSTITUTE FOR GENOMIC MEDICINE   (United States)

^o CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^p UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^q WESTMEAD HOSPITAL   (Australia)

^r NEPEAN HOSPITAL   (Australia)

^s UNIVERSITY OF SYDNEY   (Australia)

^t University of Sydney   (Australia)

^u UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^v UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^w Inflammatix Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; COHORT ANALYSIS; DISEASE; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNE RESPONSE; MODEL; MORTALITY; PERFORMANCE ASSESSMENT; PREDICTION; RISK ASSESSMENT;

ADULT; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; COMMUNITY CARE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; GENE EXPRESSION; HOSPITAL INFECTION; HUMAN; MEDICAL INTENSIVE CARE UNIT; MORTALITY; PREDICTION; PREDICTIVE VALUE; PROGNOSIS; SEPSIS; TRANSCRIPTOMICS; BLOOD; CROSS INFECTION; GENE EXPRESSION PROFILING; GENETICS; SEVERITY OF ILLNESS INDEX; THEORETICAL MODEL;

BIOLOGICAL MARKER;

BIOMARKERS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; GENE EXPRESSION PROFILING; HUMANS; MODELS, THEORETICAL; PROGNOSIS; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 85042210696     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-03078-2     Document Type: Article

References (69)

1. Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801 (2016).
2. Torio, C. M. (ahrq) & Andrews, R. M. (ahrq). National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011. HCUP Statistical Brief #160. (2013).
3. Liu, V. et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA, https://doi.org/10.1001/jama.2014.5804 (2014).
4. Kaukonen, K. M., Bailey, M., Pilcher, D., Cooper, D. J. & Bellomo, R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N. Engl. J. Med. 372, 1629-1638 (2015).
5. Opal, S. M., Dellinger, R. P., Vincent, J. L., Masur, H. & Angus, D. C. The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?. Crit. Care. Med. 42, 1714-1721 (2014).
6. Cohen, J. et al. Sepsis: a roadmap for future research. Lancet Infect. Dis. 15, 581-614 (2015).
7. Shankar-Hari, M. et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 775-787 (2016).
8. Kutz, A. et al. The TRIAGE-ProADM score for an early risk stratification of medical patients in the emergency department - development based on a multi-national, prospective, observational study. PLoS ONE 11, e0168076 (2016).
9. Rast, A., Mueller, B. & Schuetz, P. Clinical scores and blood biomarkers for early risk assessment of patients presenting to the emergency department. OA Emerg. Med. 1, 2 (2014).
10. Abraham, E. New definitions for sepsis and septic shock: continuing evolution but with much still to be done. JAMA 315, 757-759 (2016).
11. Bermejo-Martin, J. F., Tamayo, E., Andaluz-Ojeda, D., Fernández, M. M. & Almansa, R. Characterising Systemic Immune Dysfunction Syndrome (SIDS) to fill in the gaps of SEPSIS-2 and SEPSIS-3 definitions. CHEST 151, 518-519 (2017).
12. Sweeney, T. E. & Wong, H. R. Risk stratification and prognosis in sepsis: what have we learned from microarrays? Clin. Chest. Med. 37, 209-218 (2016).
13. Almansa, R. et al. Transcriptomic correlates of organ failure extent in sepsis. J. Infect. 70, 445-456 (2015).
14. Wong, H. R. et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am. J. Respir. Crit. Care. Med. 191, 309-315 (2015).
15. Davenport, E. E. et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(16)00046-1 (2016).
16. Parnell, G. et al. Aberrant cell cycle and apoptotic changes characterise severe influenza A infection - a meta-analysis of genomic signatures in circulating leukocytes. PLoS ONE 6, e17186 (2011).
17. Parnell, G. P. et al. Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions. Shock 40, 166-174 (2013).
18. Wong, H. R. et al. Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol. Genom. 30, 146-155 (2007).
19. Tsalik, E. L. et al. An integrated transcriptome and expressed variant analysis of sepsis survival and death. Genome Med. 6, 111 (2014).
20. Bolignano, D. et al. Prognostic models in the clinical arena. Aging Clin. Exp. Res. 24, 300-304 (2012).
21. Sieberts, S. K. et al. Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nat. Commun. 7, 12460 (2016).
22. Allen, G. I. et al. Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease. Alzheimers Dement. 12, 645-653 (2016).
23. Guinney, J. et al. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. Lancet Oncol. https://doi.org/10.1016/S1470-2045(16)30560-5 (2016).
24. Noren, D. P. et al. A crowdsourcing approach to developing and assessing prediction algorithms for AML prognosis. PLoS Comput. Biol. 12, e1004890 (2016).
25. Saez-Rodriguez, J. et al. Crowdsourcing biomedical research: leveraging communities as innovation engines. Nat. Rev. Genet. 17, 470-486 (2016).
26. Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1-22 (2010).
27. Wright, M. N. & Ziegler, A. ranger: A Fast Implementation of Random Forests for High Dimensional Data in C++ and R. arXiv [stat.ML] (2015).
28. Sweeney, T. E., Perumal, T. M. & Henao, R. Federated Sepsis Analysis: Sample Scores. https://doi.org/10.7303/syn6175515 (2017).
29. Pachot, A. et al. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol. Lett. 106, 63-71 (2006).
30. Bauer, P. R. et al. Diagnostic accuracy and clinical relevance of an inflammatory biomarker panel for sepsis in adult critically ill patients. Diagn. Microbiol. Infect. Dis. 84, 175-180 (2016).
31. Saito, T. & Rehmsmeier, M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS ONE 10, e0118432 (2015).
32. Mathias, B. et al. Human myeloid-derived suppressor cells are associated with chronic immune suppression after severe sepsis/septic shock. Ann. Surg. https://doi.org/10.1097/SLA.0000000000001783 (2016).
33. Pham, C. T. N. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6, 541-550 (2006).
34. Manfredi, A. A., Covino, C., Rovere-Querini, P. & Maugeri, N. Instructive influences of phagocytic clearance of dying cells on neutrophil extracellular trap generation. Clin. Exp. Immunol. 179, 24-29 (2015).
35. Masuda, S. et al. NETosis markers: quest for specific, objective, and quantitative markers. Clin. Chim. Acta 459, 89-93 (2016).
36. Nalos, M. et al. Transcriptional reprogramming of metabolic pathways in critically ill patients. Intensive Care Med. Exp. 4, 21 (2016).
37. Yang, L. et al. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat. Commun. 5, 4436 (2014).
38. Cheng, S.-C. et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).
39. Liu, T. F. et al. Fueling the flame: bioenergy couples metabolism and inflammation. J. Leukoc. Biol. 92, 499-507 (2012).
40. Tibshirani, R. Regression shrinkage and selection via the lasso: a retrospective. J. R. Stat. Soc. Ser. B Stat. Methodol. 73, 273-282 (2011).
41. Bierer, B. E., Li, R., Barnes, M. & Sim, I. A global, neutral platform for sharing trial data. N. Engl. J. Med. 374, 2411-2413 (2016).
42. Sweeney, T. E., Haynes, W. A., Vallania, F., Ioannidis, J. P. & Khatri, P. Methods to increase reproducibility in differential gene expression via meta-analysis. Nucleic Acids Res. 45, e1 (2017).
43. Spence, R. P. et al. Validation of virulence and epidemiology DNA microarray for identification and characterization of staphylococcus aureus isolates. J. Clin. Microbiol. 46, 1620-1627 (2008).
44. Howrylak, J. A. et al. Discovery of the gene signature for acute lung injury in patients with sepsis. Physiol. Genom. 37, 133-139 (2009).
45. Pankla, R. et al. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 10, R127 (2009).
46. Berdal, J. E. et al. Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza. J. Infect. 63, 308-316 (2011).
47. Dolinay, T. et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am. J. Respir. Crit. Care. Med. 185, 1225-1234 (2012).
48. Lill, M. et al. Peripheral blood RNA gene expression profiling in patients with bacterial meningitis. Front. Neurosci. 7, 33 (2013).
49. Kangelaris, K. N. et al. Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. Am. J. Physiol. Lung Cell. Mol. Physiol. 308, L1102-L1113 (2015).
50. Bermejo-Martin, J. F. et al. Host adaptive immunity deficiency in severe pandemic influenza. Crit. Care 14, R167 (2010).
51. Ahn, S. H. et al. Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans. PLoS ONE 8, e48979 (2013).
52. Tsalik, E. L. et al. Host gene expression classifiers diagnose acute respiratory illness etiology. Sci. Transl. Med. 8, 322ra11 (2016).
53. Irwin, A. D. et al. Novel biomarker combination improves the diagnosis of serious bacterial infections in Malawian children. BMC Med. Genom. 5, 13 (2012).
54. Kwan, A., Hubank, M., Rashid, A., Klein, N. & Peters, M. J. Transcriptional instability during evolving sepsis may limit biomarker based risk stratification. PLoS ONE 8, e60501 (2013).
55. Raman, S. et al. Oxidative phosphorylation gene expression falls at onset and throughout the development of meningococcal sepsis-induced multi-organ failure in children. Intensive Care Med. 41, 1489-1490 (2015).
56. Sweeney, T. E., Shidham, A., Wong, H. R. & Khatri, P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci. Transl. Med. 7, 287ra71 (2015).
57. Almansa, R. et al. Transcriptomic evidence of impaired immunoglobulin G production in fatal septic shock. J. Crit. Care 29, 307-309 (2014).
58. Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 (2006).
59. Seok, J. et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110, 3507-3512 (2013).
60. Gautier, L., Cope, L., Bolstad, B. M. & IrizarryR. A. affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307-315 (2004).
61. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47-e47 (2015).
62. Law, C. W., Yunshun, C., Wei, S. & Smyth, G. K. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
63. Pencina, M. J., D'Agostino, R. B. Sr & Steyerberg, E. W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat. Med. 30, 11-21 (2011).
64. Sweeney, T. E., Braviak, L., Tato, C. M. & Khatri, P. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir. Med 4, 213-224 (2016).
65. The Gene Ontology Consortium. Gene Ontology Consortium: going forward. Nucleic Acids Res. 43, D1049-D1056 (2014).
66. Fabregat, A. et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 44, D481-D487 (2016).
67. Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353-D361 (2017).
68. Hänzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).
69. Sweeney, T. E., Perumal, T. M. & Henao, R. A community approach to mortality prediction in sepsis via gene expression analysis: Analysis Repository. https://doi.org/10.7303/syn5612563 (2017).